Revelation Biosciences Inc (REVB) — Financial Flexibility Index
Revelation Biosciences Inc (REVB) has a Financial Flexibility Index of -1.53x as of March 2026. Free cash flow of $-3.14 Million (operating CF $-3.21 Million minus capex $71.88K) represents -2% of total liabilities ($2.06 Million). Check Revelation Biosciences Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Revelation Biosciences Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Revelation Biosciences Inc across 10 annual periods. See Revelation Biosciences Inc (REVB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Revelation Biosciences Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Revelation Biosciences Inc. For the full company profile including market capitalisation, see Revelation Biosciences Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.04x | $-8.27 Million | $-8.27 Million | $2.72 Million | ▲ +68.2% |
| 2024 | -9.56x | $-18.30 Million | $-18.32 Million | $1.91 Million | ▼ -630.4% |
| 2023 | -1.31x | $-7.29 Million | $-7.29 Million | $5.56 Million | ▲ +48.1% |
| 2022 | -2.52x | $-11.22 Million | $-11.22 Million | $4.45 Million | ▲ +50.7% |
| 2021 | -5.12x | $-10.96 Million | $-11.09 Million | $2.14 Million | ▼ -2775.9% |
| 2020 | -0.18x | $-215.07K | $-215.07K | $1.21 Million | ▼ -100.0% |
| 2019 | 1581.66x | $41.61 Million | $41.09 Million | $26.31K | ▲ +10359799.7% |
| 2018 | 0.02x | $33.44 Million | $32.58 Million | $2.19 Billion | ▲ +16.4% |
| 2017 | 0.01x | $25.05 Million | $24.25 Million | $1.91 Billion | ▲ +85.7% |
| 2016 | 0.01x | $12.18 Million | $11.60 Million | $1.73 Billion | — |